KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$11.67 USD
+0.42 (3.73%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.70 +0.03 (0.26%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Brokerage Reports
KalVista Pharmaceuticals, Inc. [KALV]
Reports for Purchase
Showing records 101 - 105 ( 105 total )
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - Spotlight on HAE: Takeaways From Our KOL Discussion
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Force Is Strong with This One; Initiating with Buy - $20 PT
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Force Is Strong with This One; Initiating with Buy - $20 PT
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J